Contract Opportunities · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
| Agency | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Solicitation Number | 75A50126R00001_RFP_NPIVS_27 |
| Notice Type | Solicitation |
| NAICS | 541714 |
| Set-Aside | No Set aside used |
| Place Of Performance | Washington, DC, 20024 |
| Posted | Oct 26, 2026 |
| Source | Federal — SAM.gov |
| Response Deadline | Nov 20, 2026 13 days left as of Nov 7, 2026 |
| Time Left | 13 days left as of 2026-11-07 |
| Primary | Laura Saddison · [email protected] |
| Official Notice | View On SAM.gov |
About this opportunity
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.
Who can apply
Set-aside: No Set aside used — as stated in the official notice: “No Set aside used”. Verify eligibility on the official notice before bidding.
Source: SAM.gov. Verify every deadline on the official notice.